truncation. c-Cbl is a cytoplasmic protein that is tyrosine been identified as Wnt receptors (Bhanot et al., 1996; Yang-Snyder et al., 1996) . Frizzled is a Drosophila polarphosphorylated in response to EGF and other cytokines, and associates with the EGF receptor via its N-terminal ity gene product required for the development of normal tissue polarity in the epidermis. Frizzled family members domain (Galisteo et al., 1995) . c-Cbl is homologous to the C. elegans protein Sli1, which was identified as a have seven transmembrane domains and a cysteinerich extracellular domain required for Wingless binding. negative regulator of signaling from the EGF receptorrelated Let23 receptor PTK in vulval development (Yoon The membrane topology of Frizzled family members is similar to that of G protein-coupled receptors, suget al., 1995) . c-Cbl may play a similar role in downregulating receptor PTK signaling in mammalian systems. v-Cbl gesting that they might be coupled to G proteins, but there is no direct evidence that this is the case. could then act as a dominant negative inhibitor of c-Cbl function by blocking its interaction with receptor PTKs, Although the signaling pathway downstream of Wnt is not fully understood, several components of this paththus upregulating mitogenic signaling.
Secreted factors that signal through receptor PTKs way are implicated in cancer (Figure 1 ). Genetic analysis in Drosophila, and the effects of ectopic expression of are also implicated in oncogenesis. At least four of the large family of FGF genes have been identified as oncoproteins on Xenopus development have defined a pathway from Wnt leading to Dishevelled, Shaggy/Zestegenes in human tumors. Moreover, although germ line mutations that constitutively activate FGFR1, -2, and white 3 (GSK3), and Armadillo (␤-catenin) (Orsulic and Peifer, 1996; Perrimon, 1996) . Dishevelled is a cyto--3 result in developmental abnormalities of the skeletal system rather than hereditary cancers, FGFR2 is complasmic protein with little homology to other proteins, except that it has a PDZ domain; it is phosphorylated monly amplified in poorly differentiated gastric carcinomas (Hattori et al., 1992) , implying that ectopic expresin response to Wingless and associates with membranes. Intriguingly, Frizzled family proteins have the sion of FGFs and inappropriate activation of FGF receptor PTKs can result in tumorigenesis.
SXV C-terminal consensus sequence required for PDZ domain binding, and Dishevelled may interact directly Secreted factors also play important roles in tumor metastasis and angiogenesis. For instance, hepatocyte with Frizzled at the membrane. Shaggy/Zeste-white 3 is a functional homolog of the growth factor (HGF)/scatter factor may play a role in metastasis, since it increases the motility and invasivemammalian glycogen synthase kinase 3 (GSK3) protein kinase. GSK3 normally suppresses the Wnt signaling ness of epithelial and endothelial cells. The HGF receptor gene (MET) is amplified and overexpressed in a numpathway, and recent biochemical analysis indicates that Wingless decreases GSK3 activity (Cook et al., 1996) . ber of tumor types, and in some cases the HGF receptor is constitutively activated (Di Renzo et al., 1995) . At least Activated Dishevelled itself could be a GSK3 inhibitor. The GSK3 substrates whose dephosphorylation propathree families of growth factor receptor PTKs are involved in angiogenesis, namely the vascular endothelial gates the Wingless signal have not yet been identified, but GSK3 is a cytoplasmic protein, and likely targets cell growth factor (VEGF) and FGF receptor families, and the Tie family. Many solid tumors produce VEGF, are Armadillo or a protein that interacts with Armadillo, such as the adenomatous polyposis coli gene product especially in response to hypoxia, a condition that commonly exists in solid tumors. Coinoculation of fibroblasts (APC), which is mutated in most colon cancers (Kinzler and Vogelstein, 1996) . Armadillo is a homolog of ␤-cateproducing a retrovirus expressing a truncated "dominant-negative" form of Flk1, one of the VEGF receptors, nin; the catenins are a family of proteins that associate with the cytoplasmic domains of cadherins, which are with a variety of tumor cell types significantly inhibits tumor growth and angiogenesis in nude mice (Millauer cell-cell interaction receptors that form part of the adherens junction. APC associates with ␣-and ␤-catenins, et al., 1994) . This supports a critical role for VEGF in tumor angiogenesis. IGF2 also proves to be critical for and by triggering degradation of free ␤-catenin this interaction appears to be critical for maintaining a low level oncogene-induced tumors in vivo (Christofori et al., 1994) .
of free ␤-catenin. GSK3 phosphorylates APC, increasing ␤-catenin binding . Thus, GSK3 The Wnt/Wingless Pathway Another secreted factor that plays a role in tumorigeneactivity could be required for ␤-catenin degradation. ␤-catenin itself is also a likely target for GSK3, since sis is Wnt1. wnt1 was one of the first examples of an oncogene activated by provirus insertion, having been wild-type GSK3 phosphorylates ␤-catenin at a conserved site whose mutation increases its stability (Yost discovered as a common site of integration in MMTVinduced mouse mammary carcinomas. Wnt1 was subet al., 1996) . The net effect of loss of APC or inactivation of GSK3 will be to increase the free pool of ␤-catenin. sequently shown to be a member of a family of secreted proteins that are important for early development; this Free ␤-catenin can signal by virtue of its association with members of TCF/LEF family of HMG box transcripfamily includes the Drosophila Wingless protein, which plays multiple roles in Drosophila development by inflution factors, an interaction that allows a LEF-1/␤-catenin complex to accumulate in the nucleus and drive tranencing cell fate decisions. Although Wnt1 expression is restricted to the nervous system in vertebrates, being scription (Behrens et al., 1996; Molenaar et al., 1996) . Consistent with a signaling function for ␤-catenin in the required for the development of the midbrain and cerebellum, other family members are expressed in the mamWnt pathway, Wingless causes accumulation of cytoplasmic Armadillo in Drosophila, and Wnt1 expression mary gland. Despite a large body of information about Wnt function, mechanistic insight into how Wnt1 transin CM57G mouse mammary cells leads to upregulation of ␤-and ␥-catenins, due to the stabilization of the soluforms has been been slow to emerge. In part this was because the Wnt receptor remained elusive. Very reble pools, which normally turn over extremely rapidly (Papkoff et al., 1996) . In this manner, Wnts can induce cently, however, proteins in the Frizzled family have Proteins that have been implicated as oncoproteins or tumor suppressor proteins are in white letters on black fill. expression of target genes; genes induced by Wingless implicated in cancer. Patched is a transmembrane protein that acts in opposition to the secreted Hedgehog include those for the transcriptional repressor Engrailed, the TGF␤ family member Decapentaplegic, and the cytoprotein in controlling cell fates and growth in many tissues (Nusse, 1996) . Vertebrate homologs of Sonic kine Hedgehog. Autocrine expression of Wnts could then lead to expression of genes that block cellular difhedgehog, Smoothened, and Patched have been identified, and recent evidence indicates that Patched is a ferentiation, and contribute to the malignant phenotype.
Cadherins and Catenins
receptor for Sonic hedgehog (Marigo et al., 1996; Stone et al., 1996) . Smoothened, a serpentine receptor-like Cadherins are surface receptors that mediate specific cell-cell interactions through homotypic association, protein distantly related to Frizzled, is negatively regulated in a tonic fashion by Patched, possibly through and also provide a means of cell-cell signaling. There are several potential connections between cadherin addirect interaction (Stone et al., 1996) , and this inhibition is relieved upon binding of Hedgehog (Figure 1 ). Actihesion and carcinogenesis. Intracellular signaling via cadherins involves activation of Src family PTKs, which vated Smoothened downregulates cAMP-dependent protein kinase (PKA), presumably through decreasing leads to tyrosine phosphorylation of catenins. Cadherinmediated signaling may act to regulate the availability cAMP levels. In principle, this could occur through negative regulation of adenylyl cyclase by a Gi family protein of free ␤-catenin (Fagotto et al., 1996) , and therefore feed into the same signaling pathway as the Wnt recepactivated by a G protein-coupled receptor such as Smoothened, but this effect is more likely to be indirect tor. ␤-catenin is a v-Src PTK substrate and its phosphorylation perturbs cadherin function in v-Src-transformed and involve the Fused protein kinase (Therond et al., 1996) . The net effect is to activate the Cubitus intercells decreasing cell-cell adhesion (Matsuyoshi et al., 1992) . p120 is a catenin-related protein, which binds ruptus zinc finger transcription factor resulting in induction of target genes such as wingless. Wingless activato cadherins but not APC, and is phosphorylated on tyrosine in response to the activation of the EGF, PDGF, tion of Frizzled in a neighboring cell leads to increased Hedgehog production, which acts back on the Wingand CSF-1 receptors and in v-Src-transformed cells (Reynolds et al., 1994) . A truncated ␤-catenin, which is less-producing cell to induce further Wingless expression. Smoothened might also act as an autocrine recepdetected in certain human cancer cell lines, disrupts the interaction between E-cadherin and ␣-catenin, and tor for Wingless; this would activate the Smoothened signaling pathway, leading to increased Wingless excauses loss of intercellular adhesiveness, implying that mutation of ␤-catenin can play a role in cancer (Oyama pression (Gailani et al., 1996;  Truncation of the Notch extracellular domain activates Notch signaling constitutively in Drosophila and verte- Hahn et al., 1996a; Johnson et al., 1996c) . Assuming that in vertebrates Patched signaling is required for cell brates. All the putative Notch-derived oncoproteins have deletions in the extracellular domain consistent fate decisions and differentiation, as it is in Drosophila, then loss of Patched would lead to constitutive activawith their being constitutively activated. Tan1 (Notch1) was initially identified as the product of a chromosomal tion of Smoothened, causing inappropriate growth of basal layer cells, ultimately resulting in carcinogenesis.
translocation, t(7;9), in a T lymphoblastic leukemia (Ellisen et al., 1991) . Tan1 induces T cell leukemias when In principle, an activating mutation in Smoothened that blocks its interaction with Patched could also play a bone marrow cells infected with a retrovirus expressing Tan1 are reintroduced into mice, establishing its credenrole in carcinogenesis. Intriguingly, the GLI1 gene, which encodes a zinc finger transcription factor related to Cutials as an oncoprotein (Pear et al., 1996) . Full-length and, less commonly, truncated Notch1 is frequently bitus interruptus, is amplified in a subset of human tumors (Kinzler and Vogelstein, 1990) ; this could have the overexpressed in thymomas arising in MMTV-c-Myc transgenic mice, suggesting that the Notch pathways same consequence as abrogating negative regulation of Smoothened by Patched.
can collaborate with c-Myc in oncogenesis (Girard et al., 1996) . Int3 (Notch4) was identified as a common The Notch Pathway At least three members of the growing Notch/Lin12 integration site for the MMTV provirus in MMTV-induced mammary carcinomas, resulting in production of an family of receptors (currently four in mammals), Tan1 (Notch1), Notch2, and Int3 (Notch4), are associated with N-terminally truncated protein. Expression of Int3 from a transgene induces mammary carcinomas (Jhappan et cancer. Notch was initially described in Drosophila, where it acts as a suppressor of cellular differentiation al., 1992). A third Notch family member, Notch2, has been implicated in tumorigenesis through the isolation when activated by interaction with one of its ligands on an adjacent cell, such as Delta or Serrate. A great deal of recombinant feline leukemia virus genomes from virally induced thymic lymphomas that encode an N-terhas been learned about the Notch/Lin12 signaling pathway from genetic analysis in Drosophila and C. elegans.
minally truncated form of Notch2 that is targeted to the nucleus (Rohn et al., 1996) . In every case, it seems likely The cytoplasmic juxtamembrane domain of Notch interacts with Suppressor of hairless [Su(H)], which is a tranthat the truncated Notch protein is signaling constitutively, thus blocking differentiation and causing continuscriptional repressor that acts together with Hairless . When Notch is activated by a ligand, Su(H) ous proliferation. Another intriguing connection between the Notch sigis released and migrates to the nucleus, where it induces expression of Hairy and Enhancer of split, which are naling pathway and transformation comes from studies on Epstein Barr virus. EBNA2, an EBV-encoded protein bHLH transcriptional repressors that block neural differentiation. There is still a debate about how Su(H) is needed for transformation of B cells, is an activator of latent viral and cellular genes. However, EBNA2 does released, with one attractive model proposing that the cytoplasmic domain of Notch is cleaved and then transnot interact directly with EBNA2-responsive sequences in its target genes. Instead, it has been found to interact locates to the nucleus with Su(H). The bound Notch would then mask the Su(H) repression domain and conwith CBF1 and drive transactivation of genes to which CBF1 is bound, thus converting a repressor into an activert it into a transcriptional activator (Hsieh et al., 1996) . Genetic analysis shows that Dishevelled is antagonistic vator (Zimber-Strobl et al., 1994) , possibly in a manner analogous to Notch bound to CBF1. to Notch. Dishevelled interacts directly with the C-terminus of Notch, and thereby potentially blocks Notch sigCytokine Receptors as Oncoproteins Until recently, members of the cytokine receptor family naling, thus providing a molecular mechanism for the inhibitory crosstalk between the Wnt and Notch had not been implicated in oncogenesis. However, the murine myeloproliferative leukemia virus oncoprotein, pathways.
Homologs of all these components of the Notch sigv-Mpl, is a mutant form of the newly discovered receptor for thrombopoietin (TPO), a megakaryocyte growth facnaling pathway have been identified in vertebrates. There are at least four Notch family receptors in mamtor. The TPO receptor (c-Mpl) is a typical member of the cytokine receptor family, which activates JAK2 and mals, and several ligands, such as Jagged. The DNAbinding protein RBP-J/CBF1/KBF2 (CBF1) is the Su(H) STAT3/STAT5, and is coupled to the ERK MAPK pathway through Shc (Gurney et al., 1995; Mu et al., 1995) . homolog, and the Hes family of bHLH proteins are Hairy/ Enhancer of split homologs. Notch function is also conv-Mpl has part of the viral Env protein fused to the C-terminus of the TPO receptor starting just to the served in vertebrates. A truncated form of Xenopus Notch lacking the extracellular domain affects cell fate N-terminal side of the transmembrane domain. v-Mpl retains the extracellular domain cytokine receptor decisions in embryos, and a soluble form of the mouse Notch intracellular domain blocks MyoD-induced myo-WSXWS motif, and is presumably activated through constitutive dimerization, thus generating a continuous genesis. Activated forms of mouse Notch associate with CBF1, triggering transcriptional activation through the growth signal and blocking differentiation. However, the exact downstream signals that are required for v-Mpl-CBF1-binding sites in the HES1 promoter (Jarriault et al., 1995) , and Hes1 can block MyoD-induced myogenmediated transformation are not known; it is not necessarily the case that the JAK/STAT pathway is essential, esis in some systems. A CBF1-independent pathway may also be involved, however, in Notch-mediated ansince proliferation induced by the erythropoietin (EPO) receptor does not require STAT activation. Activation of tagonism of MyoD-induced myogenesis (Shawber et al., 1996) .
the ERK MAPK pathway and other pathways may be important in transformation. In this connection, it is notaexample, v-Raf is a retroviral oncoprotein, and Raf1, which is a MAPKKK, can be oncogenically activated by ble that association with and activation of the EPO receptor at the cell surface by an oncogenic retroviral Env simple addition of a membrane-targeting signal. Dissection of which of these effectors is required for transforprotein, gp55, is responsible for leukemic transformation by Friend leukemia virus (Li et al., 1995b) .
mation by Ras has been made possible by the use of activated Ras mutants carrying point mutations at spe-
TGF␤ Receptors
The TGF␤ receptor and downstream signaling compocific sites in the effector domain (White et al., 1995) . These results indicate that multiple cellular pathways, nents are also targets for mutation in cancer. For instance, the gene encoding the TGF␤ receptor type II is including Raf1, are activated by Ha-Ras and contribute to Ha-Ras-induced mammalian cell transformation. Incommonly inactivated in colon carcinoma with microsatellite instability (Markowitz et al., 1995) , and the deed, it has been shown that Ras activation of Raf/ MAPK-independent pathways is sufficient to cause tu-SMAD2 and SMAD4 (DPC4) genes have also been found inactivated or deleted in colon carcinoma (Eppert et al., morigenic transformation (Khosravi-Far et al., 1996) . Among the targets for Ras required for transformation 1996; Hahn et al., 1996b) . Certain members of the Smad family (Smad1, -2, -3, and -5) are directly phosphorylated is Rac, a member of the Rho family of small G proteins. Rac itself has modest transforming activity when Gly12 by ligand-activated TGF␤ family receptors, oligomerize with Smad4, and are then translocated into the nucleus.
is mutated to Val, but it cooperates with activated Raf1 for transformation, and dominant negative Asn17 mutant Once in the nucleus, Smad protein oligomers act as transcriptional activator subunits (Liu et al., 1996) and Rac blocks Ras transformation Qiu et al., 1995) . The Ras-induced pathway leading mediate TGF␤-induced gene expression. For instance, Xenopus Smad2 interacts with the sequence-specific to Rac activation is not known. Rho is also required for Ras transformation and G1 progression. DNA binding protein, FAST-1, a member of the winged helix family of proteins, that binds to an activin-response Rho Family Proteins and the Cytoskeleton Hints that the cytoskeleton might play a critical role in element in the Mix.2 gene. Smad2 and Smad4 associate in response to TGF␤, and this interaction is required for transformation have been in evidence for many years. Transformed cells show altered patterns of expression growth inhibition (Lagna et al., 1996) . Mutant Smad2 proteins carrying point mutations found in colon carciof cytoskeletal proteins; for instance, novel tropomyosin isoforms are expressed. Transformed cells commonly nomas are no longer phosphorylated or translocated into the nucleus in response to TGF␤ (Eppert et al., have disorganized actin cytoskeletons, which may be tied to the ability of transformed cells to grow in 1996). Collectively, these observations provide strong evidence that TGF␤ receptor signaling through activaan anchorage-independent fashion. Normally adherent cells require integrin engagement to proliferate, and the tion of the Smad pathway plays an important role in tumor suppression.
concentration of ligand-occupied integrins into focal adhesions is a key factor in the anchorage and organization of actin microfilament bundles into stress fiber arrays.
Ras Family Proteins and Cancer
The Rho family of small G proteins, which regulate Activating mutations in H-Ras, K-Ras and N-Ras have actin-containing structures and plasma membrane toall been found in human tumors, and the frequency of pology, has recently assumed increasing importance in Ras mutations is among the highest for any gene in oncogenesis. Rho causes actin stress fiber formation, human cancers. Recently, two less well-known Ras-like Rac stimulates membrane ruffling and lammellipodia genes, TC21 and R-Ras, have become potential targets formation, and Cdc42 induces filopodia formation for mutational activation in human tumors. TC21 mu- (Nobes and Hall, 1995) . A number of potential effector tated at residues 22 and and 61 (equivalent to Ras 12 proteins have been found to associate preferentially with and 61) transforms NIH3T3 cells (Graham et al., 1994) , the GTP-bound forms of Rho family proteins. Cdc42 and and activating mutations in TC21 have been found in Rac bind many proteins in common through a short human tumors (Huang et al., 1995) ; R-Ras mutated at recognition sequence (CRIB) with the consensus ISXPX 4 residues 38 or 87 can transform NIH3T3 cells, although FXHXXHVG (Burbelo et al., 1995) . Among the direct tarmutations in R-Ras have not been detected in human gets for Cdc42 and Rac are several protein kinases, tumors (Cox et al., 1994; Saez et al., 1994) . Ras GAPs, including Pak1 and Rho kinase. Activated Rac and which promote Ras GTPase activity and downregulate Cdc42 stimulate the JNK/SAPK and p38 MAPKs (Coso Ras signaling, have also been implicated in tumorigeneet al., 1995; Minden et al., 1995) , possibly through bindsis. Neurofibromin, the product of the NF1 tumor suping of Rac/Cdc42 to Pak1, which leads to its activation pressor gene that is mutated in type 1 neurofibro- (Bagrodia et al., 1995) . Although it is not yet clear prematosis, is a Ras GAP with a central domain related to cisely which targets are essential for different responses p120GAP. The lack of neurofibromin leads to elevated induced by each family member, the use of specific basal levels of Ras GTP in NF1-derived schwannomas point mutations in the effector domains of these proteins (DeClue et al., 1992) , which could play a causal role in has begun to allow a dissection of the different pathways the etiology of these tumors.
that can be activated (Lamarche et al., 1996) . Thus, acti-A number of effectors for Ras proteins have been vation of Pak1 proves not to be required for Rac/Cdc42-identified, which bind preferentially to Ras in the GTPinduced cytoskeletal changes or G1/S progression. In bound state. These include Raf1, the p110 PI3 kinase contrast, a Rac mutant unable to interact with the Rho catalytic subunit, PKC, RalGDS, Rin1, and MEKK1. Sevkinase cannot induce lamellipodia or G1 progression (Lamarche et al., 1996) . eral of these have been implicated in tumorigenesis. For
The importance of Rho family small G proteins in MAP Kinase Pathways and Transformation transformation is emphasized by the large number of The MAP kinase module, which consists of three protein mutant activated GDP/GTP exchange factors for this kinases in series, a MAPK, a MAPKK, and a MAPKKK, family that have been found to possess fibroblast transhas emerged as one of the most important membraneforming activity. The first example was Dbl, an oncoproto-nucleus signaling pathways in eukaryotes. This modtein derived through artifactual truncation that occurred ule is highly conserved and extremely versatile. In yeast, during transfection. Additional examples include Vav, MAPKs are used for a variety of functions, transmitting Lbc, Tiam1, Tim, Ost, Ect2, Lsc, and FGD1. The function the response to extracellular stimuli such as pheroof these multiple exchange factors is not fully undermones, osmotic stress, and cell wall integrity. In higher stood, but they all have a core domain containing a eukaryotes, the MAPK module has been adopted to region of ‫033ف‬ residues known as the Dbl-homology transmit responses from many different types of surface domain, together with an upstream pleckstrin homology receptor, including receptor PTKs, G protein-coupled domain, which is required for GDP/GTP exchange (Quilreceptors, cytokine receptors, and possibly even the liam et al., 1995). The specificities of most of these ex-TGF␤ receptor family. Activated MAPKs are translochange factors remain to be determined, but Dbl and cated into the nucleus. In mammals, a number of nuclear Vav are pleiotropic exchange factors that can activate all MAPK targets have been identified, including the ternary three family members, whereas FGD1 can only activate complex factors in the Ets family that stimulate the exCdc42 (Olson et al., 1996) . The ability of FGD1 to transpression of the c-fos gene via the SRE. Not surprisingly, form can be explained by the ability of Cdc42 to activate constitutive activation of MAP kinase-mediated mitoRac, which in turn can activate Rho, thus leading to genic signaling pathways elicits transformation. activation of all three family members. The essential role
The three well-characterized MAPK pathways in verin transformation of the Rho family proteins underscores tebrates are the ERK, JNK/SAPK, and p38 pathways. the critical connection between the cytoskeleton and So far, only the ERK MAPK pathway has been implicated transformation.
in oncogenesis, even though the c-Jun protooncoproOther Cytoskeletal Connections tein is activated by JNK/SAPK phosphorylation and is Merlin/schwannomin, the product of the NF2 tumor suprequired for Ras transformation (Johnson et al., 1996b) . pressor gene, which is mutated in neurofibromatosis Moreover, the JNK/SAPK and p38 pathways lead to type 2 patients, is a member of the ezrin/radixin/moesin the activation of many of the same transcription fac-(ERM) family (Belliveau et al., 1995) . ERM family proteins tors, such as Elk1 and Sap1a. Perhaps transformation bind to F-actin and are localized to microvillar cores in requires phosphorylation of targets unique to ERK many cell types. The function of these proteins is not MAPKs, or else the balance of substrate phosphorylafully understood, but they can all interact with the cytotion is critical and is not achieved by p38 or JNK/SAPK. plasmic domain of CD44 , which Indeed, whereas constitutively activated mutant MEK1s, is a cell surface receptor for hyaluronan. CD44 shows which activate ERK1/2, elicit transformation of fibrostriking variability in the structure of its extracellular blasts (Cowley et al., 1994; Mansour et al., 1994) , an domain as a result of alternative splicing, and some activated mutant MEKK1, which activates both JNK/ isoforms are strongly correlated with the metastatic SAPK and p38, results in apoptosis (Johnson et al., phenotype. Recent evidence suggests that Rho regu1996a). A proapoptotic function for JNK/SAPK has also lates the CD44/ERM interaction and, conversely, that been noted in PC12 cells, where it is counteracted by this interaction may regulate Rho activation (Hirao et al., activation of ERK . Transformation of 1996). The absence of merlin could therefore affect Rho fibroblasts by upstream activators of ERK MAPK, such function and play a role in transformation.
as activated Ras and Raf1, is blocked by a dominant negative mutant of MEK1, establishing that activation Plasma Membrane-to-Nucleus Signaling Pathways of ERK MAPK is required for transformation (Cowley et Our knowledge of signaling pathways activated by al., 1994). One critical function for the Ras/ERK MAPK growth factor receptor PTKs has been advancing rapidly pathway could be mitogen-induced cyclin D expression, (Figure 2) . A number of SH2/SH3 adaptor proteins play which is needed for G1 progression (Lavoie et al., 1996) . critical roles in transducing signals from activated reRas has other effectors, however, which may play roles ceptor PTKs to downstream signaling pathways. A good in transformation. Indeed, it should be noted that transexample is Grb2, which recruits the Ras GDP/GTP exformation by activated MEK1 is blocked by microinchange factor Sos to the plasma membrane upon bindjected Ras antibody showing that direct activation of ing to activated receptor PTKs. Adaptors such as Crk, ERK1 targets is not sufficient for transformation (Cowley Nck, and Shc have been implicated in oncogenesis, et al., 1994); ERK-induced autocrine expression of either through their conversion into viral oncoproteins growth factors that act back on surface receptors that (v-Crk), or else because they transform cells when oversignal through Ras may be important for transformation. expressed (Nck and Shc). Shc is an intermediary in the Another oncoprotein connected with the ERK MAPK activation of Ras and the ERK MAPK pathway. Nck may pathway is Tpl2, originally identified as the product of an be connected to the actin cytoskeleton and Rho family oncogene associated with the progression of Moloney proteins, since Nck SH3 domains bind known Rac and/ murine leukemia virus-induced T cell lymphomas in rats. or Cdc42 targets, including Pak1. An Nck/Pak1 complex The same gene was identified as an oncogene in a transis translocated to activated growth factor receptor PTKs fection assay, and called Cot. In both cases, the oncovia the Nck SH2 domain, increasing Pak1 activity (Galisprotein is C-terminally truncated; while this truncation teo et al., 1996). Pak1 in turn can lead to activation of the JNK/SAPK and possibly the ERK MAPK pathways.
may potentiate transforming activity, however, it is not needed for transformation. Tpl2/Cot is a protein-serine of PI3,4,5P3 and PI3,4P2 in cells. It is assumed that these act as second messengers, but identification of their kinase related to the MAPKKK family, and has been shown to phosphorylate and activate MEK1 (and JNKK) effector proteins has proved difficult. Recently, however, c-Akt, which was originally identified as a protoonin vitro and to activate ERK1 (and JNK/SAPK) in vivo (Salmeron et al., 1996) . ERK MAPK activation induced coprotein, has emerged as a prime candidate. c-Akt is a protein-serine kinase with an N-terminal pleckstrin by the Tpl2 protein is blocked by dominant negative mutants of Ras and Raf-1, and a kinase-deficient Tpl2 homology (PH) domain, which, like other PH domains, binds to phosphoinositides. In vivo, c-Akt is activated mutant downregulates mitogenic signals induced by v-Ha-Ras or v-Raf, suggesting that Tpl2 interacts with by stimuli that activate PI3K, as well as by mutationally activated forms of the p110 PI3K catalytic subunit, and the ERK MAPK cascade (Patriotis et al., 1994) . The fact that three oncoproteins, Raf, Mos, and Tpl2, are direct is blocked by inhibitors of PI3K activity. Mutation of a conserved residue in the PH domain blocks c-Akt activators of MEK1 underlines the importance of the ERK MAPK pathway in transformation.
activation (Franke et al., 1995) . c-Akt activation in vivo requires phosphorylation of two residues, one in the PI3 Kinase and Transformation The PI3 kinase (PI3K) pathway is another receptor-actiactivation loop and one in the C-terminal tail. In vitro, c-Akt activity has been reported to be stimulated prefervated pathway implicated in oncogenesis. PI3K activity is stimulated by many types of extracellular signal, esentially but weakly by PI3,4P 2 (Franke et al., 1995; Klippel et al., 1997) , although in other studies no stimulation pecially those involving activation of receptor PTKs. Through the use of receptor PTK mutants that fail to was observed (James et al., 1996) . The extent of phosphoinositide activation is significantly less than obactivate PI3K and PI3K inhibitors, such as wortmannin, a role for PI3K has been delineated in a number of cellular served in vivo, suggesting that phosphorylation of the activating sites in c-Akt plays an important role in its responses, including 70K S6 kinase activation, ruffling, and chemotaxis. PI3K first came into view as an activity activation in vivo (Kohn et al., 1996) . v-Akt, the oncogene product of the AKT8 murine retrovirus, is a Gag-Akt associated with middle T antigen, the transforming protein of polyoma virus, implicating it in transformation. fusion protein, in which Gag is joined to the PH domain. Unlike c-Akt, v-Akt is myristoylated, and constitutively Subsequent work showed that binding of PI3K to MT antigen, via P.Tyr315, which is phosphorylated by the membrane-associated and activated. Thus, a plausible mechanism of Akt activation in the cell involves induc-MT-associated c-Src PTK, is crucial for transformation. The importance of PI3K in transformation has been unible binding of Akt to PI3,4P2 in the plasma membrane, where the translocated protein is activated through derscored by the recent identification of a new avian sarcoma virus, ASV16, whose oncogene encodes a Gagtrans-or autophosphorylation, which may be facilitated through PH domain-mediated dimerization. Consistent PI3K p110␣ catalytic subunit fusion oncoprotein, Gag-P3K, which has PI3K activity.
with this, membrane-anchored forms of Akt are activated regardless of whether the PH domain is present PI3K generates 3Ј phosphoinositides, PI3,4,5P 3 , PI3, 4P 2 , and PI3P, and PI3K activation increases the levels (Kohn et al., 1996) . However, even if the major role of PI3,4P2 in c-Akt activation is to recruit the protein to the chromosomal translocation in a small subset of acute promyelocytic leukemias (Chen et al., 1993) , represses membrane, it may still act as a true second messenger with other effectors.
expression of a cyclin A promoter reporter gene. One of the two possible PLZF-RAR␣ fusion proteins contains The critical targets for Akt phosphorylation are not known, but it has been shown that Akt can phosphorythe RAR␣ transactivation domains and the PLZF DNAbinding domain, and this may allow it to transactivate late and inhibit GSK3 in response to insulin, providing an intriguing connection to the Wnt pathway (Cross et rather than repress cyclin A expression, which is essential for cell cycle progression and growth. CHOP, which al., 1995). Akt may also be upstream of the 70K S6 kinase, which can phosphorylate and inhibit GSK3 as was fingered as an oncoprotein through its identification as a chromosomal translocation fusion partner of the well. Finally, recent evidence suggests that activated Akt plays a role in protection from apoptosis, which Ews RNA-binding protein in a myxoid liposarcoma, is a member of the C/EBP family of basic-leucine zipper could also be important for its transforming activity.
Other membrane-to-nucleus signaling pathways are transcription factors. CHOP can act as an antagonist of C/EBP-induced transcription, and block C/EBPinvolved in transformation. For instance, at least two components of the NF-B system have been identified induced differentiation of adipocytes (Batchvarova et al., 1995) . Transformation of fibroblasts requires a conas oncoproteins, i.e., Rel and Bcl3. As indicated above, the Notch and Wnt receptor signal pathways also play tribution from the Ews fusion partner, but CHOP may act as an oncoprotein by preventing C/EBP-induced roles in oncogenesis. However, another well-characterized membrane-to-nucleus signaling system, the JAK/ expression of differentiation genes. It is also clear that coactivator proteins, which do not STAT pathway, has to date not been implicated in carcinogenesis; indeed, proliferative signaling via cytokine bind directly to DNA, are potential targets for oncoproteins, as evidenced by the fact that adenovirus E1A receptors, such as the EPO receptor, does not require activation of JAK/STAT. Nevertheless, certain activated binds to the CBP and p300 coactivators, resulting in inactivation of certain CBP/p300 transcription stimulamutants of Hopscotch, the Drosophila JAK homolog, cause a leukemia-like phenotype owing to overproliferatory functions (Arany et al., 1995) . Another example of an oncoprotein that does not bind directly to DNA is tion of blood cells, which requires Drosophila STAT (Yan et al., 1996) . It would be interesting to look for similar Bmi1, which is a chromatin structural protein related to the Polycomb family of Drosophila repressors that is activating mutants in human leukemias.
upregulated by proviral integration in MuLV-induced thymomas (van Lohuizen et al., 1991) . Such proteins Nuclear Proteins and Cancer The number of oncogenic proteins that act in the nucleus appear to regulate and switch off large blocks of chromatin. Bmi1 may act by blocking expression of genes has continued to rise steadily. These include novel transcription factors, chromatin regulatory proteins, and a required for lymphoid differentiation. Pml, which was uncovered as a translocation partner variety of transcriptional regulators. Many of these have been identified as the products of fusion genes generof RAR␣ in promyelocytic leukemia (PML), is a component of a novel nuclear structure, called PODS, whose ated by chromosomal translocations in leukemias. Several oncogenes encode transcriptional activators, and function is still somewhat enigmatic (Dyck et al., 1994; Koken et al., 1994) . In cultured cells, expression of the they will not be reviewed here. It should be noted, however, that the thorny issue of the critical target genes Pml-RAR␣ protein disrupts PODS in a retinoic acid reversible fashion; since PML is reverted by retinoic treatthat need to be induced by such oncoproteins is still unresolved. In this connection, v-Jun appears to have ment of patients, the oncogenic activity of Pml-RAR␣ action is likely to involve disorganization of PODS. Conattenuated transcriptional activation function compared to c-Jun (Gao et al., 1996) , and this may be true for other versely, Pml, through its PODS organizing activity, acts as a growth suppressor. PODS are also disrupted by oncoproteins that are transcriptional activators.
A building theme is the function of oncoproteins as adenovirus E4-ORF3, which is required for viral replication (Doucas et al., 1996) , implying that PODS play a transcriptional repressors. The first example was v-ErbA, which is a repressor of thyroxine receptor (c-ErbA) inrole in DNA replication. The VHL gene is mutated in the hereditary cancer duced erythroid differentiation genes. WT1, the product of the Wilms' tumor suppressor gene, has also been syndrome, von Hippel Lindau disease, which predisposes to renal carcinoma and pheochromocytoma. VHL shown to be a repressor of certain genes, antagonizing the Egr family of transcriptional activators. Another reproves to be an alternative A type subunit of the RNA polymerase II cofactor Elongin (SIII), which stimulates cent example is v-Qin, the oncogene product of ASV31, which acts as a repressor and is a member of the HNFtranscription elongation by RNA polymerase II in vitro, and is assumed to ensure complete gene transcription 3/forkhead family of transcriptional factors (Li et al., 1995a) . Evi1, whose expression is activated in murine (Duan et al., 1995; Kibel et al., 1995) . Elongin is a heterotrimer consisting of a transcriptionally active A subunit myeloid leukemias by retroviral insertions and in human acute myelogenous leukemia by chromosomal translotogether with B and C regulatory subunits. Replacement of the normal Elongin A subunit with VHL inhibits it eloncations and inversions, interferes with myeloid differentiation and is also a repressor (Lopingco and Perkins, gation activity (Duan et al., 1995) . Presumably, this regulates the levels of particular transcripts that are subject 1996).
The promyelocytic leukemia Kruppel-like zinc finger to transcriptional pausing. The absence of VHL activity could allow the overexpression of specific proteins, in-(PLZF) protein, which is fused to the retinoic acid receptor ␣ (RAR␣) protein as a result of a variant t (11;17) cluding positive growth regulators. Intriguingly, the ELL gene, which is frequently fused to the trithorax-like MLL has been found in eIF-4E-overexpressing NTH 3T3 cells, although the mechanisms of upregulation appear to difgene on chromosome 11 as a result of t(11;19) translocations in acute myeloid leukemias, encodes a distinct fer. Both ODC and cyclin D1 are implicated in G1 progression, and it is interesting to note that eIF-4E requires RNA polymerase II elongation factor, providing another connection between the regulation of transcription elonRas function and, like Ras, cooperates with v-Myc in transformation. Finally, overexpression of elongation gation and cell growth (Shilatifard et al., 1996) .
Brca1 and Brca2 are huge proteins whose disruption factor EF-1␣ increases sensitivity to transformation, and an N-terminally truncated form of EF-1␣ is implicated is the underlying cause of a large fraction of hereditary breast and ovarian cancer. The subcellular localization as an oncoprotein in prostatic cancer. of Brca1 has been hotly debated, but current opinion favors a nuclear localization. Brca1 is essential for early
The Cell Cycle and Cancer mouse development, which gives little clue to its funcDirect connections between the cell cycle and cancer tion, although it may govern expression of cell cycle have been evident for some time (Sherr, 1996) . After regulators. Brca1 has not been shown to have DNAsome initial uncertainty, it is now clear that the p16 Cdk binding activity, but the C-terminal 335 residues of Brca1 inhibitor gene is a major target for mutational inactivahave transactivation function when fused to a DNA-bindtion in human cancers. In addition, specific mutations ing domain (Chapman and Verma, 1996) . This transactiin p16 are the underlying cause of one type of hereditary vation activity is abolished by point mutations in this melanoblastoma. Surprisingly, there is no evidence that region, which occur naturally in affected individuals, the three other members of the p16 Cdk inhibitor family, supporting the idea that Brca1 transactivating activity p15, p18, and p19, are mutated in human cancer. An is physiologically relevant.
emerging paradigm, however, is that one component of Finally, the Dek-Can and Set-Can fusion proteins aristhe p16-cyclin D/Cdk4-Rb axis is mutationally inactiing from leukemia-associated translocations found in vated in most cancer cells (Sherr, 1996) . Thus, a tumor leukemia contain the C-terminal domains of Can, which may have mutations that lead to loss of p16 or Rb, or contains repeats found in nucleoporins. The Can protein upregulation of cyclin D expression, or a mutation that is localized to the nuclear and cytoplasmic faces of the renders Cdk4 insensitive to p16. The net result is that nuclear envelope, whereas the Can fusion proteins are Rb and Rb family members are constitutively inactivated found exclusively in the nucleus (Fornerod et al., 1995) .
in such cells, providing a trigger for progression from Potentially, this altered distribution perturbs nuclear im-G1 into S phase. The best evidence is that cyclin D is port or export of proteins or RNAs.
not required for cell cycle progression in cells bearing a mutation in one component of this axis, and that p16 fails to block the growth of such cells.
Protein Synthesis and Oncogenesis
An increase in the rate of protein synthesis initiation
The other key component in the G1-to-S transition is cyclin E, which acts in conjunction with Cdk2. Cyclin E can also lead to transformation. Two different initiation factors have been implicated. Overexpression of eIF-4E, is overexpressed in some cancer cells, although the mechanism has not been established (Keyomarsi and the mRNA cap-binding subunit of the eIF-4F initiation factor, elicits fibroblast transformation (Lazaris-KarPardee, 1993) . Mutations or deletions that eliminate a C-terminal Cdk phosphorylation site enhance cyclin E atzas et Smith et al., 1990) . The second initiation factor, eIF-2, is a heterotrimer that forms a ternary function by blocking ubiquitin-mediated degradation, thus leading to its accumulation. It is possible that mutacomplex with GTP and Met-tRNAi, and is needed to deliver Met-tRNAi to the initiation complex. eIF-2 is negtions of this type will be found in cancers. So far, none of the members of the p21 family of Cdk inhibitors, which atively regulated through phosphorylation of Ser-51 in the ␣ subunit; this blocks the action of the eIF-2 GDPhave a broader inhibitory specificity than the p16 family, has been implicated in tumorigenesis, despite an exten-GTP exchange factor, which is needed to reactivate eIF-2 after its cargo is delivered. Phosphorylation of eIFsive search for mutations in the genes for p21, p27, and p57. It has recently been shown, however, that the 2␣ plays a major role in negative regulation of initiation of protein synthesis; two protein kinases are known that adenovirus E1A and human papilloma virus E7 transforming proteins have the ability to counteract the Cdk phosphorylate eIF-2␣ at Ser-51, namely the doublestranded RNA dependent protein kinase (PKR) and a inhibitory activity of p27 (Mal et al., 1996) . This property of E1A may be important in its ability to override TGF␤-heme-regulated protein kinase. Expression of a kinaseinactive mutant form of PKR causes fibroblast transforinduced growth inhibition and trigger the growth of quiescent cells, which have high levels of p27. mation (Koromilas et al., 1992; Meurs et al., 1993) as a result of a decrease in eIF-2␣ phosphorylation. ConsisNew players in the regulation of the cell cycle are continually being uncovered, but none with a clear cut tent with a role for eIF-2␣ phosphorylation in transformation mediated by kinase-inactive PKR, overexpression involvement in oncogenesis has been discovered recently. However, an intriguing connection has emerged of an Ala-51 mutant eIF-2␣ also causes transformation. Presumably, the general increase in protein synthesis between an old friend, Cdc25, and transformation. Cdc25A and Cdc25B, but not Cdc25C, can cooperate initiation capacity results in increased translation of poorly translated mRNAs encoding specific proteins with activated Ras to transform primary rodent fibroblasts (Galaktionov et al., 1995b) . Cdc25s are dual-specthat are important for growth and cell cycle progression. Indeed, enhanced expression of several proteins, inificity phosphatases that dephosphorylate the negative regulatory phosphates at Thr-14 and Tyr-15 in Cdks, cluding cyclin D1 and ornithine decarboxylase (ODC), leading to their activation. Cdc25C activates cyclin with Raf1 and localizes Raf1 to mitochondrial membranes . Moreover, mitochondrially B/Cdc2 at the G2/M transition, but the cyclin/Cdk target(s) for Cdc25A and Cdc25B has not been unequivolocalized Raf1 protects IL3-dependent cells from apoptosis induced by IL3 withdrawal, whereas a kinase-inaccally established. There is reasonable evidence, however, that Cdc25A acts on Cdk2 complexes, and that tive form of Raf1 potentiates killing. Bcl2 has also been found to associate with R-Ras (Fernandez-Sarabia and Cdc25A activity is required for the G1/S transition. It is possible that cyclin D-Cdk4 complexes may also be Bischoff, 1993) , which could play a role in Raf1 activation. One potential target for Bcl2-associated Raf1 is Cdc25 targets. The exact connection between Cdc25A and Ras is not clear, but it has been suggested that RasBad itself. A recent clue to the function of Bcl2 family proteins comes from the finding that their structure is activated Raf might directly regulate Cdc25A activity through phosphorylation (Galaktionov et al., 1995a) . related to the diphtheria toxin channel (Muchmore et al., 1996) , and that they can act as ion channels in vitro. Another intriguing connection between Cdc25A and -B and the cell cycle is that the expression of both Cdc25
Channels with distinct properties may be formed by different combinations of Bcl2 family members. This genes is increased at the transcriptional level by c-Myc leading to accumulation of Cdc25 protein (Galaktionov system is also a target for viral intervention; for instance, adenovirus E1B 19K binds to Bax, thus inactivating it et al., 1996). Both Cdc25 genes contain c-Myc/Maxbinding sites in the first intron, which respond transcrip- (Han et al., 1996) . Another important apoptotic regulator is p53, which tionally to increased c-Myc expression. Moreover, expression of c-Myc leads to activation of cyclin E-Cdk2 is activated by DNA damage; activated p53 induces or represses the expression of a number of target genes and cyclin D-Cdk4 complexes in quiescent cells (Steiner et al., 1995) . Further evidence that Cdc25A is an impor- (Levine, 1997 [this issue of Cell] ). Among these is the p21 Cdk inhibitor p21, which acts on cyclin-Cdk4/6 and tant target for c-Myc is that depletion of Cdc25A by antisense RNA expression or antisense-oligonucleotide cyclin-Cdk2 complexes, playing a role in the arrest of cells in G1. Activation of p53 is also required for the treatment blocks c-Myc-induced apoptosis. Consistent with a role for Cdc25A/B in carcinogenesis, Cdc25A/B induction of apoptosis in response to some but not all signals. The finding that c-Myc induces apoptosis in the RNA and protein are found to be overexpressed in a variety of tumors, including breast carcinomas (Galaktiabsence of growth factors has been another key finding. c-Myc is a double-edged sword, being capable of drivonov et al., 1995b). Moreover, adenovirus E1A increases Cdc25A activity and expression in quiescent cells, and ing a cell through the cell cycle under appropriate conditions or provoking cell death under suboptimal condiCdc25A is required for adenovirus to induce DNA synthesis (Spitkovsky et al., 1996) . Cdc25A and Cdc25B are tions. Signals from the IGF1 receptor PTK counteract the c-Myc-induced apoptotic pathway at many levels, also targets for TGF␤, being downregulated at the RNA and protein level following TGF␤ treatment.
and this allows c-Myc to express its proliferative potential and explains the requirement for IGF1 for growth of most cultured cells (Harrington et al., 1994) . Apoptosis An emerging theme in carcinogenesis is the acquired Adherent endothelial and epithelial cells require integrin engagement for survival, and in the absence of ability of tumor cells to avoid undergoing apoptosis in response to DNA damage or other conditions that would attachment to a substratum undergo apoptosis (Meredith et al., 1993; Boudreau et al., 1995) . One of the conseinduce a normal cell to commit suicide. Our understanding of the mechanisms underlying programmed cell quences of the accumulated mutations in a carcinoma may be to provide a signal that mimics integrin occudeath, or apoptosis, has grown explosively in the past few years. Signal transduction pathways leading from pancy. This will have the net effect of providing a signal that permits cells to grow in the absence of anchorreceptors, such as Fas and the TNF receptor, to the activation of effectors of cell death, such as the Caspase age, and at the same time interdicts the normal apoptotic response to lack of integrin engagement. Interestprotease family, have been elucidated (Nagata, 1997 [this issue of Cell] ). Bcl2 family proteins are key regulaingly, activated R-Ras increases integrin ligand affinity, whereas dominant negative mutant R-Ras reduces cell tors of this pathway. These proteins hetero-and homodimerize, and have been categorized as either proadhesiveness (Zhang et al., 1996) . apoptotic (e.g. Bax or Bad) or anti-apoptotic (e.g. Bcl2 or Bcl-XL). Thus, the balance of pro-versus anti-apoptotic Conclusions Bcl2 family members in cells dictates cellular response.
One striking conclusion is that oncogenesis is intimately bcl2 was identified at the breakpoint of a t(14;18) tranconnected with a failure of incipient tumor cells to differscription in acute lymphocytic B cell leukemia. Expresentiate. This can be the consequence of mutations in sion of a bcl2 transgene results in the expansion of the B highly conserved genes that regulate cell fate decisions cell population due to a failure of these cells to undergo and differentiation, such as Notch and Patched. In addinormal programmed cell death and elimination.
tion, a number of oncogenic transcription factors act as Both Bad and Bcl2 have recently been found to be repressors to block transcription of genes required for regulated through phosphorylation. Bad is phosphorydifferentiation. The importance of constitutively actilated at Ser-112/136 in response to IL3 treatment of vated mitogenic signaling pathways in oncogenesis has cells that require IL3 for survival, and this results in become increasingly obvious. Activated forms of several 14-3-3 binding (Zha et al., 1996 catenins, which were once thought of simply as compo- that perturbation of such networks through mutation will Di Renzo, M.F., Poulsom, R., Olivero, M., Comoglio, P.M., and Lebe a fundamental cause of cancer. moine, N.R. (1995) . Expression of the Met/hepatocyte growth factor receptor in human pancreatic cancer. Cancer Res. 55, 1129-1138.
